StonvexLoading…
StonvexStonvexStonvexCore line items from TRU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $4.58B | $4.18B | $3.83B | $968.70M |
Operating Income | $857.80M | $666.70M | $128.50M | $-236.30M |
Net Income | $455.40M | $284.40M | $-206.20M | $-318.80M |
EPS (Diluted) | $2.32 | $1.45 | $-1.07 | $-1.65 |
Total Assets | $11.11B | $10.98B | $11.11B | Not available |
Total Liabilities | $6.57B | $6.67B | $7.00B | Not available |
Cash & Equivalents | $853.60M | $679.50M | $476.20M | Not available |
Free Cash Flow OCF − CapEx | $661.60M | $516.70M | $334.70M | Not available |
Shares Outstanding | 192.40M | 194.90M | 193.80M | Not available |